Impact of prior lines of systemic therapy (PST) on the efficacy of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC)

D. Rischin; N. I. Khushalani; C. D. Schmults; A. Guminski; A. L. S. Chang; K. D. Lewis; A. M. Lim; L. Hernandez-Aya; B. G. M. Hughes; D. Schadendorf; A. Hauschild; E. Stankevich; J. Booth; S. Li; Z. Chen; J. Desai; I. Lowy; M. G. Fury; M. R. Migden

Impact of prior lines of systemic therapy (PST) on the efficacy of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC)

D. Rischin, N. I. Khushalani, C. D. Schmults, A. Guminski, A. L. S. Chang, K. D. Lewis, A. M. Lim, L. Hernandez-Aya, B. G. M. Hughes, D. Schadendorf, A. Hauschild, E. Stankevich, J. Booth, S. Li, Z. Chen, J. Desai, I. Lowy, M. G. Fury, M. R. Migden

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Number of pages	2
Journal	Annals of Oncology
Volume	30
Publication status	Published - Dec 2019
Externally published	Yes
Event	Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO) - Geneva, Switzerland Duration: 11 Dec 2019 → 14 Dec 2019

Cite this

Rischin, D., Khushalani, N. I., Schmults, C. D., Guminski, A., Chang, A. L. S., Lewis, K. D., Lim, A. M., Hernandez-Aya, L., Hughes, B. G. M., Schadendorf, D., Hauschild, A., Stankevich, E., Booth, J., Li, S., Chen, Z., Desai, J., Lowy, I., Fury, M. G., & Migden, M. R. (2019). Impact of prior lines of systemic therapy (PST) on the efficacy of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC). Annals of Oncology, 30.

@article{51a963cb40fd4218917e731fab722ca5,

title = "Impact of prior lines of systemic therapy (PST) on the efficacy of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC)",

author = "D. Rischin and Khushalani, {N. I.} and Schmults, {C. D.} and A. Guminski and Chang, {A. L. S.} and Lewis, {K. D.} and Lim, {A. M.} and L. Hernandez-Aya and Hughes, {B. G. M.} and D. Schadendorf and A. Hauschild and E. Stankevich and J. Booth and S. Li and Z. Chen and J. Desai and I. Lowy and Fury, {M. G.} and Migden, {M. R.}",

year = "2019",

month = dec,

language = "English",

volume = "30",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

note = "Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO) ; Conference date: 11-12-2019 Through 14-12-2019",

}

Rischin, D, Khushalani, NI, Schmults, CD, Guminski, A, Chang, ALS, Lewis, KD, Lim, AM, Hernandez-Aya, L, Hughes, BGM, Schadendorf, D, Hauschild, A, Stankevich, E, Booth, J, Li, S, Chen, Z, Desai, J, Lowy, I, Fury, MG & Migden, MR 2019, 'Impact of prior lines of systemic therapy (PST) on the efficacy of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC)', Annals of Oncology, vol. 30.

TY - JOUR

T1 - Impact of prior lines of systemic therapy (PST) on the efficacy of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC)

AU - Rischin, D.

AU - Khushalani, N. I.

AU - Schmults, C. D.

AU - Guminski, A.

AU - Chang, A. L. S.

AU - Lewis, K. D.

AU - Lim, A. M.

AU - Hernandez-Aya, L.

AU - Hughes, B. G. M.

AU - Schadendorf, D.

AU - Hauschild, A.

AU - Stankevich, E.

AU - Booth, J.

AU - Li, S.

AU - Chen, Z.

AU - Desai, J.

AU - Lowy, I.

AU - Fury, M. G.

AU - Migden, M. R.

PY - 2019/12

Y1 - 2019/12

M3 - Abstract/Meeting Abstract

SN - 0923-7534

VL - 30

JO - Annals of Oncology

JF - Annals of Oncology

T2 - Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO)

Y2 - 11 December 2019 through 14 December 2019

ER -